These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27454209)

  • 1. Use of rotavirus vaccines in preterm babies on the neonatal unit.
    Kilich E; Sadarangani M
    Expert Rev Vaccines; 2016 Dec; 15(12):1463-1465. PubMed ID: 27454209
    [No Abstract]   [Full Text] [Related]  

  • 2. Timely immunisation of premature infants against rotavirus in the neonatal intensive care unit.
    Ladhani SN; Ramsay ME
    Arch Dis Child Fetal Neonatal Ed; 2014 Nov; 99(6):F445-7. PubMed ID: 25053636
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for In-Neonatal Intensive Care Unit Administration of Live, Attenuated Rotavirus Vaccination.
    Briggs-Steinberg C; Shah S
    Am J Perinatol; 2018 Dec; 35(14):1443-1448. PubMed ID: 29883980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.
    Bines JE; Danchin M; Jackson P; Handley A; Watts E; Lee KJ; West A; Cowley D; Chen MY; Barnes GL; Justice F; Buttery JP; Carlin JB; Bishop RF; Taylor B; Kirkwood CD;
    Lancet Infect Dis; 2015 Dec; 15(12):1389-97. PubMed ID: 26318715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-Label Pilot Study to Compare the Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5) Administered on an Early Alternative Dosing Schedule with Those of RV5 Administered on the Recommended Standard Schedule.
    Saleh E; Eichner B; Clark DW; Gagliano ME; Troutman JM; Harrington L; McNeal M; Clements D
    J Pediatric Infect Dis Soc; 2018 Feb; 7(1):82-85. PubMed ID: 28340179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccination in preterm infants: a neonatal guidance chart to aid timely immunisation.
    Kilich E; Anthony M
    Arch Dis Child Fetal Neonatal Ed; 2015 Sep; 100(5):F465. PubMed ID: 25862725
    [No Abstract]   [Full Text] [Related]  

  • 9. Rotavirus vaccination in the neonatal intensive care units: where are we? A rapid review of recent evidence.
    Sicard M; Bryant K; Muller ML; Quach C
    Curr Opin Pediatr; 2020 Feb; 32(1):167-191. PubMed ID: 31851055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccines: development, current issues and future prospects.
    Cunliffe NA; Bresee JS; Hart CA
    J Infect; 2002 Jul; 45(1):1-9. PubMed ID: 12217724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
    Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
    Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Pavlic D; Bogdanovic-Sakran N; Boniface K; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2018; 14(8):2082-2087. PubMed ID: 29688121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreword: ESPID/ESPGHAN evidence-based recommendations for rotavirus vaccination in Europe.
    Vesikari T
    J Pediatr Gastroenterol Nutr; 2008 May; 46 Suppl 2():v-vi. PubMed ID: 18460975
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination.
    Hofstetter AM; Lacombe K; Klein EJ; Jones C; Strelitz B; Jacobson E; Ranade D; Ward ML; Mijatovic-Rustempasic S; Evans D; Wikswo M; Bowen MD; Parashar UD; Payne DC; Englund JA
    Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29212881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations for vaccination against ROTAvirus in PREMature newborns (ROTAPREM)].
    Álvarez Aldeán J; Ares Segura S; Díaz González C; Montesdeoca Melián A; García Sánchez R; Boix Alonso H; Moreno-Pérez D;
    An Pediatr (Engl Ed); 2019 Sep; 91(3):205.e1-205.e7. PubMed ID: 31288982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the pentavalent rotavirus vaccine in subjects after 1 or 2 doses in the rotavirus efficacy and safety trial.
    Bernstein D
    Pediatrics; 2008 Jan; 121(1):223; author reply 223-4. PubMed ID: 18166579
    [No Abstract]   [Full Text] [Related]  

  • 18. The pentavalent rotavirus vaccine, RotaTeq.
    Matson DO
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):195-9. PubMed ID: 17055370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus vaccine timeliness in special care nurseries.
    Crawford NW; Hunt RW
    Arch Dis Child Fetal Neonatal Ed; 2014 May; 99(3):F251-2. PubMed ID: 24596405
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale and implementation policy for use of oral, live, reassortant rotavirus vaccine in the neonatal intensive care unit.
    Shah SI
    Adv Neonatal Care; 2008 Jun; 8(3):148-9. PubMed ID: 18535419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.